drugset / Trial / NCT04205929

Use of Curcumin to Treat Unfavorable Bleeding Patterns in Contraceptive Implant Users

NCT04205929 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

The investigators plan to study the effects of curcumin, the active ingredient in the spice turmeric, on the irregular bleeding experienced by women who use the contraceptive implant.

Timeline

Start
2020-04-15
Primary completion
2022-11-05
Completion
2023-08-01

Outcome

Missed primary endpoint

paper Daily use of curcumin did not improve bleeding patterns in users of the etonogestrel contraceptive implant experiencing frequent or prolonged bleeding patterns. PMID 37116825 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Curcumin Small molecule 600 mg Oral

Indications